JANUS HENDERSON GROUP PLC - TAKEDA PHARMACEUTICAL CO LTD ownership

TAKEDA PHARMACEUTICAL CO LTD's ticker is TAK and the CUSIP is 874060205. A total of 285 filers reported holding TAKEDA PHARMACEUTICAL CO LTD in Q1 2022. The put-call ratio across all filers is 0.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
JANUS HENDERSON GROUP PLC ownership history of TAKEDA PHARMACEUTICAL CO LTD
ValueSharesWeighting
Q3 2023$6,002,639
-3.7%
388,018
-2.2%
0.00%0.0%
Q2 2023$6,233,267
-8.2%
396,771
-3.7%
0.00%0.0%
Q1 2023$6,786,753
+1.7%
411,818
-3.7%
0.00%
-20.0%
Q4 2022$6,671,496
+16.2%
427,660
-51.6%
0.01%
+25.0%
Q3 2022$5,739,734
-10.6%
884,252
+93.5%
0.00%0.0%
Q2 2022$6,417,000
-4.2%
457,075
-2.3%
0.00%
+33.3%
Q1 2022$6,698,000
+19.9%
467,760
+14.1%
0.00%
+50.0%
Q4 2021$5,586,000
-26.7%
409,810
-11.9%
0.00%
-33.3%
Q3 2021$7,624,000
-21.4%
465,420
-19.3%
0.00%
-25.0%
Q2 2021$9,705,000
-18.4%
576,634
-11.5%
0.00%
-20.0%
Q1 2021$11,898,000
+12.3%
651,594
+11.9%
0.01%0.0%
Q4 2020$10,599,000
-15.3%
582,351
-16.9%
0.01%
-28.6%
Q3 2020$12,509,000
-7.7%
701,149
-7.2%
0.01%
-12.5%
Q2 2020$13,550,000
+21.4%
755,737
+2.7%
0.01%0.0%
Q1 2020$11,166,000
-53.3%
735,599
-39.2%
0.01%
-33.3%
Q4 2019$23,886,000
-2.6%
1,210,656
-15.1%
0.01%
-7.7%
Q3 2019$24,536,000
-6.4%
1,426,481
-3.6%
0.01%
-7.1%
Q2 2019$26,205,000
-12.1%
1,480,487
+1.2%
0.01%
-17.6%
Q1 2019$29,809,000
+159.7%
1,463,400
+114.5%
0.02%
+142.9%
Q4 2018$11,477,000682,3320.01%
Other shareholders
TAKEDA PHARMACEUTICAL CO LTD shareholders Q1 2022
NameSharesValueWeighting ↓
Adelphi Capital LLP 7,931,116$140,381,00032.92%
Endurant Capital Management LP 932,967$16,514,0006.51%
Glenview Capital Management 26,430,828$467,826,0004.24%
Paulson & Co. 13,244,711$234,431,0003.98%
Blackcrane Capital, LLC 172,955$3,061,0003.88%
NINE MASTS CAPITAL Ltd 1,474,286$26,146,0003.74%
Velanne Asset Management Ltd 286,640$5,074,0003.22%
LMR Partners LLP 4,563,591$80,884,0002.95%
SECTOR GAMMA AS 796,299$14,094,0002.26%
MFN Partners Management, LP 785,000$13,895,0002.21%
View complete list of TAKEDA PHARMACEUTICAL CO LTD shareholders